[1]
Blauvelt, A., Reich, K., Lebwohl, M., Burge, D., Arendt, C., Peterson, L., Rolleri, R. and Gottlieb, A. 2018. Certolizumab Pegol for the Treatment of Patients with Moderate-to-Severe Chronic Plaque Psoriasis: An Overview of 3 Randomized Controlled Trials. SKIN The Journal of Cutaneous Medicine. 2, S1 (Feb. 2018), S3. DOI:https://doi.org/10.25251/skin.2.supp.3.